10.1016/j.bbrc.2019.01.103 Summary Keywords heart failure, cognitive impairment, type 2 diabetes, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors Citation Riemma MA, Mele E, Donniacuo M, Telesca M, Bellocchio G, Castaldo G, Rossi F, De Angelis A, Cappetta D, Urbanek K and Berrino L (2024) Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
Collectively, these studies underscore the significance of investigating the role of GSH in breast cancer patient prognosis, stressing the necessity of regulating GSH usage to prevent non-standardized intake and decrease post-chemotherapy recurrence
Studies have shown that massage therapy has modest, short-term benefits for fibromyalgia symptoms
About this article Cite this article Pountos, I., Panteli, M., Lampropoulos, A
547,548 While not fully understood, these pathways offer potential targets for therapies to enhance hepatocyte regeneration
10.1136/jnnp.46.3.255 J
